HOME Top Market Reports High-Throughput Screening Market by Technology (Cell-based Assays (2D & 3D Cell Culture), Lab-on-a-chip, Bioinformatics), Application (Target Identification, Primary Screening, Toxicology), Product (Reagent & Instruments), End User - Forecast to 2021

High-Throughput Screening Market by Technology (Cell-based Assays (2D & 3D Cell Culture), Lab-on-a-chip, Bioinformatics), Application (Target Identification, Primary Screening, Toxicology), Product (Reagent & Instruments), End User - Forecast to 2021

By: marketsandmarkets.com
Publishing Date: November 2016
Report Code: BT 2220

 

  Speak to Analyst Enquiry Before Buying  
purchase report
download pdf  request for customisation


The high-throughput screening market (HTS) is estimated to grow at a CAGR of 7.8% from 2016 to 2021 to reach USD 18.83 Billion by 2021. Market growth can be attributed to the growing adoption of open innovative models in the pharmaceutical and biotechnology industry and technological advancements like automation and miniaturization, increasing R&D spending and rising government funding. Emerging markets and growing research activities in toxicology and stem cells provide significant growth opportunities for the market. On the other hand, the high cost and time-consuming nature of HTS techniques are restraining the growth of this market during the forecast period.

In this report the global market is segmented on the basis of product and service, technology, application end user and region. Based on product and service, the market is segmented into consumables and reagents, instruments, & software and services. In 2015, consumables and reagents accounted for the largest share of the global high-throughput screening products and services market. The availability of a wide range of reagents and continual product developments and innovations contributes to their largest share in HTS products and services market. Based on application, the HTS market is segmented into target identification, primary screening, toxicology assessment and others. The other application segment includes hospitals and clinical laboratories, food and agriculture industries, & environmental laboratories.

Based on technology, the market is segmented into cell-based assays; lab-on-a-chip, ultra high-throughput screening market, label-free technology and bioinformatics. The cell-based assays segment is subsegmented into 2D cell culture, 3D cell culture and perfusion cell culture. 3D cell culture is further divided into scaffold-based technology (includes hydrogels and inert matrix/solid scaffolds segment) and scaffold-free technology (includes microplates, hanging-drop plates, ultra-low binding plates and others segment). The hydrogels scaffold-based technology is further subsegmented into animal-derived (includes matrigel and collagen segment), agarose/alginate and synthetic hydrogels. The other scaffold-free technology segment includes microfluidics, 3D bioreactors & magnetic levitation, and 3D bioprinting.

Based on the end users, the market is classified into pharmaceutical and biotechnology companies, academic and government research institutes, contract research organizations (CROs) and other end users. The other end users segment includes hospitals & clinics, and food, agriculture, and environmental industries.

Geographically, the global market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. In 2015, North America commanded largest share of the market, whereas, APAC and Latin America markets are projected to register highest growth rates in this market. The high growth in these regions is mainly attributed to the increasing R&D spending; growing trend of outsourcing drug discovery services; growing public-private partnerships; and increasing government funding.

The global high-throughput screening market is fragmented, with the presence of many small companies which operate in their respective market segments. These small market players operating at regional- and local-levels are challenging the market share of the leading players in this market. In order to maintain their market shares, leading players in the market are continuously developing new technologies and upgrading their existing products to enhance their product portfolios. Some of the prominent players in the global market include Agilent Technologies, Inc. (U.S.), Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), PerkinElmer, Inc. (U.S.) and Tecan Group Ltd. (Switzerland), Merck Millipore (U.S.), Bio-Rad laboratories (U.S.), Hamilton Company (U.S.), Axxam S.p.A. (Italy) and Aurora Biomed (Canada).

Target Audience:

  • HTS Instrument & Reagent Manufacturers
  • Pharmaceutical and Biotechnological Companies
  • High-content Screening Database, Service, and Software Providers
  • Business Research and Consulting Firms
  • Academic Institutes and Government Organizations
  • Clinical Research Organizations (CROs) & Clinical Manufacturing Organizations (CMOs)
  • Healthcare Institutions (Hospitals, Medical Schools, and Outpatient Clinics)
  • Government Bodies
  • Venture Capitalists

To know about the assumptions considered for the study, download the pdf brochure

Scope of the Report

The research report categorizes the global market into the following segments and subsegments:

  • Global High-throughput Screening Market, By Technology
    • Cell-based Assays
    • 2D Cell Culture
    • 3D Cell Culture
      • Scaffold-based Technologies
        • Hydrogels
          • Animal-derived
            • Matrigel
            • Collagen
          • Alginate/Agarose
          • Synthetic
        • Inert Matrix/Solid Scaffolds
      • Scaffold-free Technologies
        • Microplate
        • Hanging-drop Plates
        • Ultra-low Binding Plates
        • Other Scaffold-free Technologies
    • Perfusion Cell Culture
  • Global High-throughput Screening Market, by Application
    • Target Identification
    • Primary Screening
    • Toxicology Assessment
    • Other Applications
  • Global High-throughput Screening Market, by Products and Services
    • Consumables and Reagents
    • Instruments
    • Software and Services
  • Global High-throughput screening market, by End User
    • Pharmaceutical and Biotechnology Companies
    • Academic and Government Research Institutes
    • Contract Research Organizations
    • Other End Users
  • Global High-throughput screening market, by Region
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • France
      • U.K.
      • Italy
      • Spain
      • Rest of Europe
    • Asia-Pacific
      • Japan
      • China
      • Australia
      • Rest of Asia-Pacific
    • Rest of the World
      • Latin America
      • Middle East and Africa

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Product Analysis

  • Product matrix, which gives a detailed comparison of the product portfolios of the top companies

Company Information

  • Detailed analysis and profiling of additional market players (Up to 5)

Table of Contents

1 Introduction (Page No. - 20)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered in the Report
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 24)
    2.1 Research Approach
    2.2 Market Size Estimation
    2.3 Market Breakdown and Data Triangulation
           2.3.1 Key Data From Secondary Sources
           2.3.2 Key Data From Primary Sources
           2.3.3 Assumptions for the Study

3 Executive Summary (Page No. - 31)

4 Premium Insights (Page No. - 36)
    4.1 High-Throughput Screening: Market Overview
    4.2 Asia-Pacific: High-Throughput Screening Services Market, By Type
    4.3 Market: Geographic Snapshot
    4.4 Market Size, By Application
    4.5 Market: Geographic Mix

5 Market Overview (Page No. - 40)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Market Drivers
                    5.2.1.1 Growing Adoption of Open Innovation Models in Pharmaceutical and Biotechnology Companies
                    5.2.1.2 Rising Government Funding
                    5.2.1.3 Increasing R&D Spending
                    5.2.1.4 Technological Advancements
           5.2.2 Market Restraints
                    5.2.2.1 Capital-Intensive Nature of HTS
                    5.2.2.2 Complexities in the Field of Assay Development
           5.2.3 Market Opportunities
                    5.2.3.1 High Growth Opportunities in Emerging Markets
                    5.2.3.2 Growing Research Activities in Toxicology and Stem Cells

6 Industry Insights (Page No. - 47)
    6.1 Introduction
    6.2 Porter’s Five Forces Analysis
           6.2.1 Threat of New Entrants
           6.2.2 Threat of Substitutes
           6.2.3 Bargaining Power of Suppliers
           6.2.4 Bargaining Power of Buyers
           6.2.5 Competitive Rivalry
    6.3 Technological Trends
           6.3.1 Label-Free Technology, an Emerging Trend
           6.3.2 Automation & Miniaturization of HTS Techniques
    6.4 HTS in Drug Discovery Process

7 High-Throughput Screening Market, By Product & Service (Page No. - 51)
    7.1 Introduction
    7.2 Consumables & Reagents
    7.3 Instruments
    7.4 Software & Services

8 High-Throughput Screening Market, By Technology (Page No. - 57)
    8.1 Introduction
    8.2 Cell-Based Assays
           8.2.1 2d Cell Culture
           8.2.2 3D Cell Culture
                    8.2.2.1 Scaffold-Based Technology
                               8.2.2.1.1 Hydrogels
                                             8.2.2.1.1.1 Animal-Derived Hydrogels
                                             8.2.2.1.1.2 Alginate/Agarose
                                             8.2.2.1.1.3 Synthetic Hydrogels
                               8.2.2.1.2 Inert Matrix/Solid Scaffolds
                    8.2.2.2 Scaffold-Free Technology
                               8.2.2.2.1 Microplates
                               8.2.2.2.2 Hanging-Drop Plates
                               8.2.2.2.3 Ultra-Low Binding Plates
                               8.2.2.2.4 Other Scaffold-Free Technologies
           8.2.3 Perfusion Cell Culture
    8.3 Lab-On-A-Chip
    8.4 Ultra-High-Throughput Screening
    8.5 Label-Free Technology
    8.6 Bioinformatics

9 High-Throughput Screening Market, By Application (Page No. - 85)
    9.1 Introduction
    9.2 Target Identification
    9.3 Primary Screening
    9.4 Toxicology Assessment
    9.5 Other Applications

10 High-Throughput Screening Market, By End User (Page No. - 92)
     10.1 Introduction
     10.2 Pharmaceutical and Biotechnology Companies
     10.3 Academic and Government Research Institutes
     10.4 Contract Research Organizations
     10.5 Other End Users

11 High-Throughput Screening Market, By Region (Page No. - 99)
     11.1 Introduction
     11.2 North America
             11.2.1 U.S.
             11.2.2 Canada
     11.3 Europe
             11.3.1 Germany
             11.3.2 U.K.
             11.3.3 France
             11.3.4 Italy
             11.3.5 Spain
             11.3.6 Rest of Europe
     11.4 Asia-Pacific
             11.4.1 Japan
             11.4.2 China
             11.4.3 India
             11.4.4 Rest of Asia-Pacific
     11.5 Rest of the World
             11.5.1 Latin America
             11.5.2 Middle East and Africa

12 Competitive Landscape (Page No. - 197)
     12.1 Introduction
     12.2 Strategic Overview
     12.3 Market Share Analysis
     12.4 Competitive Situation and Trends
             12.4.1 Product Launches and Upgrades
             12.4.2 Agreements, Collaborations, and Partnerships
             12.4.3 Expansions
             12.4.4 Acquisitions
             12.4.5 Other Developments

13 Company Profiles (Page No. - 206)
(Overview, Products and Services, Financials, Strategy & Development)*
     13.1 Introduction
     13.2 Agilent Technologies, Inc.
     13.3 Danaher Corporation
     13.4 Perkinelmer, Inc.
     13.5 Thermo Fisher Scientific Inc.
     13.6 Axxam S.P.A.
     13.7 Tecan Group Ltd.
     13.8 Bio-Rad Laboratories, Inc.
     13.9 Hamilton Company
     13.10 Sigma-Aldrich Corporation (A Division of Merck Millipore)
     13.11 Aurora Biomed, Inc.

*Details on Overview, Products and Services, Financials, Strategy & Development Might Not Be Captured in Case of Unlisted Companies.

14 Appendix (Page No. - 236)
     14.1 Insights of Industry Experts
     14.2 Discussion Guide
     14.3 Other Developments
     14.4 Knowledge Store: Marketsandmarkets’ Subscription Portal
     14.5 Introducing RT: Real-Time Market Intelligence
     14.6 Available Customizations
     14.7 Related Reports
     14.8 Author Details


List of Tables (237 Tables)

Table 1 Impact Analysis: Market Drivers
Table 2 Impact Analysis: Market Restraints
Table 3 Impact Analysis: Market Opportunities
Table 4 High-Throughput Screening Market Size, By Product, 2016–2021 (USD Million)
Table 5 High-Throughput Screening Consumables & Reagents Market Size, By Country, 2014–2021 (USD Million)
Table 6 High-Throughput Screening Instruments Market Size, By Country, 2014–2021 (USD Million)
Table 7 High-Throughput Screening Software & Services Market Size, By Country, 2014–2021 (USD Million)
Table 8 Market Size, By Technology, 2014–2021 (USD Million)
Table 9 Market Size for Cell-Based Assays, By Type, 2014–2021 (USD Million)
Table 10 Market Size for Cell-Based Assays, By Country, 2014–2021 (USD Million)
Table 11 Market Size for 2d Cell Culture, By Country, 2014–2021 (USD Million)
Table 12 Market Size for 3D Cell Culture, By Type, 2014–2021 (USD Million)
Table 13 Market Size for 3D Cell Culture, By Country, 2014–2021 (USD Million)
Table 14 Market Size for Scaffold-Based Technology, By Type, 2014–2021 (USD Million)
Table 15 Market Size for Scaffold-Based Technology, By Country, 2014–2021 (USD Million)
Table 16 Market Size for Hydrogels, By Type, 2014–2021 (USD Million)
Table 17 Market Size for Hydrogels, By Country, 2014–2021 (USD Million)
Table 18 Market Size for Animal-Derived Hydrogels, By Type, 2014–2021 (USD Million)
Table 19 Market Size for Animal-Derived Hydrogels, By Country, 2014–2021 (USD Million)
Table 20 Market Size for Matrigel, By Country, 2014–2021 (USD Million)
Table 21 Market Size for Collagen, By Country, 2014–2021 (USD Million)
Table 22 Market Size for Alginate/Agarose, By Country, 2014–2021 (USD Million)
Table 23 Market Size for Synthetic Hydrogels, By Country, 2014–2021 (USD Million)
Table 24 Market Size for Inert Matrix/Solid Scaffolds, By Country, 2014–2021 (USD Million)
Table 25 Market Size for Scaffold-Free Technology, By Type, 2014–2021 (USD Million)
Table 26 Market Size for Scaffold-Free Technology, By Country, 2014–2021 (USD Million)
Table 27 Market Size for Microplates, By Country, 2014–2021 (USD Million)
Table 28 Market Size for Hanging-Drop Plates, By Country, 2014–2021 (USD Million)
Table 29 Market Size for Ultra-Low Binding Plates, By Country, 2014–2021 (USD Million)
Table 30 Market Size for Other Scaffold-Free Technologies, By Country, 2014–2021 (USD Million)
Table 31 Market Size for Perfusion Cell Culture, By Country, 2014–2021 (USD Million)
Table 32 Market Size for Lab-On-A-Chip, By Country, 2014–2021 (USD Million)
Table 33 Ultra-High-Throughput Screening Market Size, By Country, 2014–2021 (USD Million)
Table 34 Market Size for Label-Free Technology, By Country, 2014–2021 (USD Million)
Table 35 Market Size for Bioinformatics, By Country, 2014–2021 (USD Million)
Table 36 Market Size, By Application, 2014–2021 (USD Million)
Table 37 Market Size for Target Identification, By Country, 2014–2021 (USD Million)
Table 38 Market Size for Primary Screening, By Country, 2014–2021 (USD Million)
Table 39 Market Size for Toxicology Assessment, By Country, 2014–2021 (USD Million)
Table 40 Market Size for Other Applications, By Country, 2014–2021 (USD Million)
Table 41 Market Size, By End User, 2014–2021 (USD Million)
Table 42 Market Size for Pharmaceutical and Biotechnology Companies, By Country, 2014–2021 (USD Million)
Table 43 Market Size for Academic and Government Research Institutes, By Country, 2014–2021 (USD Million)
Table 44 Market Size for Contract Research Organizations, By Country, 2014–2021 (USD Million)
Table 45 Market Size for Other End Users, By Country, 2014–2021 (USD Million)
Table 46 Market Size, By Region, 2014–2021 (USD Million)
Table 47 North America: Market Size, By Country, 2014–2021 (USD Million)
Table 48 North America: Market Size, By Technology, 2014–2021 (USD Million)
Table 49 North America: Cell-Based Assays Market Size, By Type, 2014–2021 (USD Million)
Table 50 North America: 3D Cell Culture Market Size, By Type, 2014–2021 (USD Million)
Table 51 North America: Scaffold-Based Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 52 North America: Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 53 North America: Animal-Derived Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 54 North America: Scaffold-Free Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 55 North America: Market Size, By Application, 2014–2021 (USD Million)
Table 56 North America: Market Size, By Product, 2014–2021 (USD Million)
Table 57 North America: Market Size, By End User, 2014–2021 (USD Million)
Table 58 U.S.: Market Size, By Technology, 2014–2021 (USD Million)
Table 59 U.S.: Cell-Based Assays Market Size, By Type, 2014–2021 (USD Million)
Table 60 U.S.: 3D Cell Culture Market Size, By Type, 2014–2021 (USD Million)
Table 61 U.S.: Scaffold-Based Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 62 U.S.: Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 63 U.S.: Animal-Derived Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 64 U.S.: Scaffold-Free Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 65 U.S.: Market Size, By Application, 2014–2021 (USD Million)
Table 66 U.S.: Market Size, By Product, 2014–2021 (USD Million)
Table 67 U.S.: Market Size, By End User, 2014–2021 (USD Million)
Table 68 Canada: Market Size, By Technology, 2014–2021 (USD Million)
Table 69 Canada: Cell-Based Assays Market Size, By Type, 2014–2021 (USD Million)
Table 70 Canada: 3D Cell Culture Market Size, By Type, 2014–2021 (USD Million)
Table 71 Canada: Scaffold-Based Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 72 Canada: Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 73 Canada: Animal-Derived Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 74 Canada: Scaffold-Free Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 75 Canada: Market Size, By Application, 2014–2021 (USD Million)
Table 76 Canada: Market Size, By Product, 2014–2021 (USD Million)
Table 77 Canada: Market Size, By End User, 2014–2021 (USD Million)
Table 78 Pharmaceutical Industry R&D Expenditure in Europe, By Country, 2014 (USD Million)
Table 79 Europe: Market Size, By Country, 2014–2021 (USD Million)
Table 80 Europe: Market Size, By Technology, 2014–2021 (USD Million)
Table 81 Europe: Cell-Based Assays Market Size, By Type, 2014–2021 (USD Million)
Table 82 Europe: 3D Cell Culture Market Size, By Type, 2014–2021 (USD Million)
Table 83 Europe: Scaffold-Based Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 84 Europe: Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 85 Europe: Animal-Derived Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 86 Europe: Scaffold-Free Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 87 Europe: Market Size, By Application, 2014–2021 (USD Million)
Table 88 Europe: Market Size, By Product, 2014–2021 (USD Million)
Table 89 Europe: Market Size, By End User, 2014–2021 (USD Million)
Table 90 Germany: Market Size, By Technology, 2014–2021 (USD Million)
Table 91 Germany: Cell-Based Assays Market Size, By Type, 2014–2021 (USD Million)
Table 92 Germany: 3D Cell Culture Market Size, By Type, 2014–2021 (USD Million)
Table 93 Germany: Scaffold-Based Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 94 Germany: Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 95 Germany: Animal-Derived Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 96 Germany: Scaffold-Free Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 97 Germany: Market Size, By Application, 2014–2021 (USD Million)
Table 98 Germany: Market Size, By Product, 2014–2021 (USD Million)
Table 99 Germany: Market Size, By End User, 2014–2021 (USD Million)
Table 100 U.K.: Market Size, By Technology, 2014–2021 (USD Million)
Table 101 U.K.: Cell-Based Assays Market Size, By Type, 2014–2021 (USD Million)
Table 102 U.K.: 3D Cell Culture Market Size, By Type, 2014–2021 (USD Million)
Table 103 U.K.: Scaffold-Based Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 104 U.K.: Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 105 U.K.: Animal-Derived Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 106 U.K.: Scaffold-Free Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 107 U.K.: Market Size, By Application, 2014–2021 (USD Million)
Table 108 U.K.: Market Size, By Product, 2014–2021 (USD Million)
Table 109 U.K.: Market Size, By End User, 2014–2021 (USD Million)
Table 110 France: Market Size, By Technology, 2014–2021 (USD Million)
Table 111 France: Cell-Based Assays Market Size, By Type, 2014–2021 (USD Million)
Table 112 France: 3D Cell Culture Market Size, By Type, 2014–2021 (USD Million)
Table 113 France: Scaffold-Based Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 114 France: Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 115 France: Animal-Derived Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 116 France: Scaffold-Free Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 117 France: Market Size, By Application, 2014–2021 (USD Million)
Table 118 France: Market Size, By Product, 2014–2021 (USD Million)
Table 119 France: Market Size, By End User, 2014–2021 (USD Million)
Table 120 Italy: Market Size, By Technology, 2014–2021 (USD Million)
Table 121 Italy: Cell-Based Assays Market Size, By Type, 2014–2021 (USD Million)
Table 122 Italy: 3D Cell Culture Market Size, By Type, 2014–2021 (USD Million)
Table 123 Italy: Scaffold-Based Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 124 Italy: Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 125 Italy: Animal-Derived Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 126 Italy: Scaffold-Free Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 127 Italy: High-Throughput Screening Market Size, By Application, 2014–2021 (USD Million)
Table 128 Italy: High-Throughput Screening Market Size, By Product, 2014–2021 (USD Million)
Table 129 Italy: High-Throughput Screening Market Size, By End User, 2014–2021 (USD Million)
Table 130 Spain: High-Throughput Screening Market Size, By Technology, 2014–2021 (USD Million)
Table 131 Spain: Cell-Based Assays Market Size, By Type, 2014–2021 (USD Million)
Table 132 Spain: 3D Cell Culture Market Size, By Type, 2014–2021 (USD Million)
Table 133 Spain: Scaffold-Based Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 134 Spain: Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 135 Spain: Animal-Derived Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 136 Spain: Scaffold-Free Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 137 Spain: High-Throughput Screening Market Size, By Application, 2014–2021 (USD Million)
Table 138 Spain: High-Throughput Screening Market Size, By Product, 2014–2021 (USD Million)
Table 139 Spain: High-Throughput Screening Market Size, By End User, 2014–2021 (USD Million)
Table 140 RoE: High-Throughput Screening Market Size, By Technology, 2014–2021 (USD Million)
Table 141 RoE: Cell-Based Assays Market Size, By Type, 2014–2021 (USD Million)
Table 142 RoE: 3D Cell Culture Market Size, By Type, 2014–2021 (USD Million)
Table 143 RoE: Scaffold-Based Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 144 RoE: Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 145 RoE: Animal-Derived Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 146 RoE: Scaffold-Free Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 147 RoE: High-Throughput Screening Market Size, By Application, 2014–2021 (USD Million)
Table 148 RoE: High-Throughput Screening Market Size, By Product, 2014–2021 (USD Million)
Table 149 RoE: High-Throughput Screening Market Size, By End User, 2014–2021 (USD Million)
Table 150 APAC: High-Throughput Screening Market Size, By Country, 2014–2021 (USD Million)
Table 151 APAC: High-Throughput Screening Market Size, By Technology, 2014–2021 (USD Million)
Table 152 APAC: Cell-Based Assays Market Size, By Type, 2014–2021 (USD Million)
Table 153 APAC: 3D Cell Culture Market Size, By Type, 2014–2021 (USD Million)
Table 154 APAC: Scaffold-Based Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 155 APAC: Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 156 APAC: Animal-Derived Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 157 APAC: Scaffold-Free Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 158 APAC: High-Throughput Screening Market Size, By Application, 2014–2021 (USD Million)
Table 159 APAC: High-Throughput Screening Market Size, By Product, 2014–2021 (USD Million)
Table 160 APAC: High-Throughput Screening Market Size, By End User, 2014–2021 (USD Million)
Table 161 Japan: High-Throughput Screening Market Size, By Technology, 2014–2021 (USD Million)
Table 162 Japan: Cell-Based Assays Market Size, By Type, 2014–2021 (USD Million)
Table 163 Japan: 3D Cell Culture Market Size, By Type, 2014–2021 (USD Million)
Table 164 Japan: Scaffold-Based Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 165 Japan: Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 166 Japan: Animal-Derived Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 167 Japan: Scaffold-Free Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 168 Japan: High-Throughput Screening Market Size, By Application, 2014–2021 (USD Million)
Table 169 Japan: High-Throughput Screening Market Size, By Product, 2014–2021 (USD Million)
Table 170 Japan: High-Throughput Screening Market Size, By End User, 2014–2021 (USD Million)
Table 171 China: High-Throughput Screening Market Size, By Technology, 2014–2021 (USD Million)
Table 172 China: Cell-Based Assays Market Size, By Type, 2014–2021 (USD Million)
Table 173 China: 3D Cell Culture Market Size, By Type, 2014–2021 (USD Million)
Table 174 China: Scaffold-Based Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 175 China: Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 176 China: Animal-Derived Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 177 China: Scaffold-Free Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 178 China: High-Throughput Screening Market Size, By Application, 2014–2021 (USD Million)
Table 179 China: High-Throughput Screening Market Size, By Product, 2014–2021 (USD Million)
Table 180 China: High-Throughput Screening Market Size, By End User, 2014–2021 (USD Million)
Table 181 India: High-Throughput Screening Market Size, By Technology, 2014–2021 (USD Million)
Table 182 India: Cell-Based Assays Market Size, By Type, 2014–2021 (USD Million)
Table 183 India: 3D Cell Culture Market Size, By Type, 2014–2021 (USD Million)
Table 184 India: Scaffold-Based Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 185 India: Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 186 India: Animal-Derived Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 187 India: Scaffold-Free Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 188 India: High-Throughput Screening Market Size, By Application, 2014–2021 (USD Million)
Table 189 India: High-Throughput Screening Market Size, By Product, 2014–2021 (USD Million)
Table 190 India: High-Throughput Screening Market Size, By End User, 2014–2021 (USD Million)
Table 191 RoAPAC: High-Throughput Screening Market Size, By Technology, 2014–2021 (USD Million)
Table 192 RoAPAC: Cell-Based Assays Market Size, By Type, 2014–2021 (USD Million)
Table 193 RoAPAC: 3D Cell Culture Market Size, By Type, 2014–2021 (USD Million)
Table 194 RoAPAC: Scaffold-Based Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 195 RoAPAC: Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 196 RoAPAC: Animal-Derived Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 197 RoAPAC: Scaffold-Free Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 198 RoAPAC: High-Throughput Screening Market Size, By Application, 2014–2021 (USD Million)
Table 199 RoAPAC: High-Throughput Screening Market Size, By Product, 2014–2021 (USD Million)
Table 200 RoAPAC: High-Throughput Screening Market Size, By End User, 2014–2021 (USD Million)
Table 201 RoW: High-Throughput Screening Market Size, By Region, 2014–2021 (USD Million)
Table 202 RoW: High-Throughput Screening Market Size, By Technology, 2014–2021 (USD Million)
Table 203 RoW: Cell-Based Assays Market Size, By Type, 2014–2021 (USD Million)
Table 204 RoW: 3D Cell Culture Market Size, By Type, 2014–2021 (USD Million)
Table 205 RoW: Scaffold-Based Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 206 RoW: Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 207 RoW: Animal-Derived Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 208 RoW: Scaffold-Free Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 209 RoW: High-Throughput Screening Market Size, By Application, 2014–2021 (USD Million)
Table 210 RoW: High-Throughput Screening Market Size, By Product, 2014–2021 (USD Million)
Table 211 RoW: High-Throughput Screening Market Size, By End User, 2014–2021 (USD Million)
Table 212 Latin America: High-Throughput Screening Market Size, By Technology, 2014–2021 (USD Million)
Table 213 Latin America: Cell-Based Assays Market Size, By Type, 2014–2021 (USD Million)
Table 214 Latin America: 3D Cell Culture Market Size, By Type, 2014–2021 (USD Million)
Table 215 Latin America: Scaffold-Based Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 216 Latin America: Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 217 Latin America: Animal-Derived Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 218 Latin America: Scaffold-Free Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 219 Latin America: High-Throughput Screening Market Size, By Application, 2014–2021 (USD Million)
Table 220 Latin America: High-Throughput Screening Market Size, By Product, 2014–2021 (USD Million)
Table 221 Latin America: High-Throughput Screening Market Size, By End User, 2014–2021 (USD Million)
Table 222 Middle East and Africa: High-Throughput Screening Market Size, By Technology, 2014–2021 (USD Million)
Table 223 Middle East and Africa: Cell-Based Assays Market Size, By Type, 2014–2021 (USD Million)
Table 224 Middle East and Africa: 3D Cell Culture Market Size, By Type, 2014–2021 (USD Million)
Table 225 Middle East and Africa: Scaffold-Based Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 226 Middle East and Africa: Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 227 Middle East and Africa: Animal-Derived Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 228 Middle East and Africa: Scaffold-Free Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 229 Middle East and Africa: High-Throughput Screening Market Size, By Application, 2014–2021 (USD Million)
Table 230 Middle East and Africa: High-Throughput Screening Market Size, By Product, 2014–2021 (USD Million)
Table 231 Middle East and Africa: High-Throughput Screening Market Size, By End User, 2014–2021 (USD Million)
Table 232 Market Developments, By Company, 2013–2016
Table 233 Product Launches and Upgrades, 2013–2016
Table 234 Agreements, Collaborations, and Partnerships, 2013–2016
Table 235 Expansions, 2013–2016
Table 236 Acquisitions, 2013–2016
Table 237 Other Developments, 2013–2016


List of Figures (39 Figures)

Figure 1 High-Throughput Screening Market
Figure 2 Research Design
Figure 3 Market Size Estimation Methodology: Bottom-Up Approach
Figure 4 Market Size Estimation Methodology: Top-Down Approach
Figure 5 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 6 Data Triangulation Methodology
Figure 7 Global High-Throughput Screening Market, By Products and Services, 2016 vs 2021 (USD Million)
Figure 8 Global High-Throughput Screening Market, By Application, 2016 vs 2021 (USD Million)
Figure 9 Global High-Throughput Screening Market, By Technology, 2016 vs 2021 (USD Million)
Figure 10 Global High-Throughput Screening Market, By End User, 2016 vs 2021 (USD Million)
Figure 11 Geographic Snapshot: High-Throughput Screening Market
Figure 12 Adoption of Open Innovative Models By Pharmaceutical & Biotechnology Companies is Propelling Growth in the High-Throughput Screening Market
Figure 13 Pharmaceutical & Biotechnology Companies Commanded the Largest Share of the Asia-Pacific High-Throughput Screening Market in 2015
Figure 14 The U.S. Accounted for the Largest Share of the High-Throughput Screening Technologies Market in 2015
Figure 15 The Target Identification Segment Will Continue to Dominate the High-Throughput Screening Market in 2021
Figure 16 North America to Witness the Highest Growth Rate in the High-Throughput Screening Market During the Forecast Period
Figure 17 High-Throughput Screening Market: Drivers, Restraints, and Opportunities
Figure 18 Pharmaceutical R&D Expenditure, By Geography, 2000 vs 2010 vs 2014
Figure 19 Porter’s Five Forces Analysis
Figure 20 Drug Discovery Process
Figure 21 High-Throughput Screening Market Segmentation, By Product
Figure 22 High-Throughput Screening Market, By Technology, 2016 vs 2021 (USD Million)
Figure 23 High-Throughput Screening Market for Cell-Based Assays, By Type, 2016 vs 2021 (USD Million)
Figure 24 High-Throughput Screening Market for 3D Cell Culture, By Type, 2016 vs 2021 (USD Million)
Figure 25 High-Throughput Screening Market, By Application, 2016
Figure 26 High-Throughput Screening Market Size, By End User, 2016-2021 (USD Million)
Figure 27 High-Throughput Screening Market: Geographic Snapshot (2016)
Figure 28 North America: HTS Market Snapshot
Figure 29 Asia-Pacific: HTS Market Snapshot
Figure 30 Key Developments in the High-Throughput Screening Market, 2013–2016
Figure 31 Global High-Throughput Screening Market Share Analysis, By Key Player, 2015
Figure 32 Financial Performances of the Leading Market Players
Figure 33 Agilent Technologies, Inc.: Company Snapshot
Figure 34 Danaher Corporation: Company Snapshot
Figure 35 Perkinelmer, Inc.: Company Snapshot
Figure 36 Thermo Fisher Scientific, Inc.: Company Snapshot
Figure 37 Tecan Group Ltd.: Company Snapshot
Figure 38 Bio-Rad Laboratories, Inc.: Company Snapshot
Figure 39 Merck Millipore: Company Snapshot

The global high-throughput screening (HTS) market is projected to reach USD 18.83 Billion by 2021, at a CAGR of 7.8% from 2016 to 2021. The market growth can be attributed to a number of factors such as growing adoption of open innovative models in the pharmaceutical and biotechnology industry and technological advancements like automation and miniaturization, increasing R&D spending and rising government funding. Emerging markets and growing research activities in toxicology and stem cells provide significant growth opportunities for the market. Label-free technology and automation and miniaturization of HTS techniques are the key trends of this market. However, the high cost and time-consuming nature of HTS techniques are restraining the growth of this market during the forecast period.

In this report the global market is segmented on the basis of product and service, technology, application end user and region. Based on product and service, the market is segmented into consumables and reagents, instruments, & software and services. In 2015, consumables and reagents accounted for the largest share of the global high-throughput screening products and services market. The availability of a wide range of reagents and continual product developments and innovations contributes to their largest share in HTS products and services market.

Based on technology, the market is segmented into cell-based assays; lab-on-a-chip, ultra high-throughput screening market, label-free technology and bioinformatics. The cell-based assays segment is subsegmented into 2D cell culture, 3D cell culture and perfusion cell culture. 3D cell culture is further divided into scaffold-based technology (includes hydrogels and inert matrix/solid scaffolds segment) and scaffold-free technology (includes microplates, hanging-drop plates, ultra-low binding plates and others segment). The hydrogels scaffold-based technology is further subsegmented into animal-derived (includes matrigel and collagen segment), agarose/alginate and synthetic hydrogels. The other scaffold-free technology segment includes microfluidics, 3D bioreactors & magnetic levitation, and 3D bioprinting. In 2015, 2D cell culture accounted for the largest share of the global market, by technology. The factors contributing to the growth of this technology segment includes low cost, ease of use, and the ability to use cell-based assays in multiwell microplates together with automated workstations.

Based on application, the HTS market is segmented into target identification, primary screening, toxicology assessment and others. The other application segment includes hospitals and clinical laboratories, food and agriculture industries, & environmental laboratories. In 2015, target identification accounted for the largest share in the global HTS application market. The increasing adoption of HTS technique for the identification of targets is the major factor contributing for the largest share of this segment.

Furthermore, on the basis of end users, the market is classified into pharmaceutical and biotechnology companies, academic and government research institutes, contract research organizations (CROs) and other end users. The other end users segment includes hospitals & clinics, and food, agriculture, and environmental industries. The pharmaceutical and biotechnology companies segment accounted for the largest share in the global HTS market, by end users. The extensive use of the HTS technology in pharmaceutical and biotechnology companies for drug discovery applications is the major factor driving the growth of this market.

In 2015, North America accounted for the largest share of the global high-throughput screening market, followed by Europe, Asia-Pacific, and RoW. Growth in the developed markets in North America and Europe is mainly driven by the large spending on pharmaceutical R&D and high adoption of HTS and availability of government funding, and the presence of major companies in this region. As opposed to the North American and European markets, the demand in the APAC and Latin American markets is primarily driven by the growth in the overall healthcare industry. Increasing R&D spending; growing trend of outsourcing drug discovery services; growing public-private partnerships; and increasing government funding are some factors that will fuel the growth of HTS market in these regions.

High-Throughput Screening Market

The major players in the high-throughput screening market are Agilent Technologies, Inc. (U.S.), Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), PerkinElmer, Inc. (U.S.) and Tecan Group Ltd. (Switzerland), Merck Millipore (U.S.), Bio-Rad laboratories (U.S.), Hamilton Company (U.S.), Axxam S.p.A. (Italy) and Aurora Biomed (Canada).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Biotechnology Markets on KnowledgeStore
Request Demo